Skip to main content

Ventas Value Stock - Dividend - Research Selection

Ventas

ISIN: US92276F1003 , WKN: 878380

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to ?Ventas? or the ?Company? mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Analysts: Healthcare REITs Show A Dichotomy Of Performance

2023-09-22
It's never easy to figure out Wall Street, where bad news can be good for stocks or vice versa. Sometimes a stock can be flying high, only to have a well-known analyst spoil the party with a downgrade. The reverse also is true, as was the case this week with some healthcare real estate investment trusts (REITs). Over the past three trading days, healthcare REITs have been the worst-performing REIT subsector. Six healthcare REITs lost between 4% and 11.5%. Eleven more healthcare REITs are also in

BMO Capital Maintains Ventas (VTR) Outperform Recommendation

2023-09-22

Healthcare REITs: Recovery And Relapse

2023-09-22
Healthcare REITs' recovery from the pandemic varies among sub-sectors. Senior Housing shows promise, while others face challenges. Read an analysis here.

Ventas price target lowered to $51 from $52 at BMO Capital

2023-09-22
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ventas Inc. stock falls Friday, underperforms market

2023-09-22
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

'Little recourse but to downgrade' Frontier Air, says Citi: 4 big analyst cuts

2023-09-21
Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Brighthouse Financial, Frontier, nCino, and Ventas. Frontier (NASDAQ:ULCC) shares were sliding Thursday after Citi downgraded the budget airline to Neutral from Buy and cut its price target to $5.50 from $16.00, as reported in real-time on InvestingPro. "We had expected Frontier’s seat mile cost profile to have provided some operational support, relative to some other domestic discount carriers,” wrote Citi.

Thursday’s Top Analyst Upgrades and Downgrades: Bausch Health, Disney, IBM, Kimco Realty, Pinterest, Western Digital and More

2023-09-21
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

3 Once-In-A-Decade REIT Buying Opportunities

2023-09-21
REITs offer a once-in-a-decade opportunity according to Principal Asset Management. Check out three of our favorite REIT buying opportunities to profit.

Ventas Inc. stock falls Thursday, underperforms market

2023-09-21
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Raymond James Downgrades Ventas (VTR)

2023-09-20